Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma

Z. K. Mirza, K. K. Das, J. Slate, R. N. Mapitigama, P. S. Amenta, L. H. Griffel, L. Ramsundar, J. Watari, K. Yokota, H. Tanabe, T. Sato, Y. Kohgo, K. M. Das

Research output: Contribution to journalArticle

32 Scopus citations

Abstract

Background: Some forms of gastric intestinal metaplasia (GIM) may be precancerous but the cellular phenotype that predisposes to gastric carcinogenesis is not well characterised. Mucin staining, as a means of differentiating GIM, is difficult. A monoclonal antibody, mAb Das-1 (initially called 7E12H12), whose staining is phenotypically specific to colon epithelium, was used to investigate this issue. Methods: Using mAb Das-1, by a sensitive immunoperoxidase assay, we examined histologically confirmed GIM specimens from two countries, the USA and Japan. A total of 150 patients comprised three groups: group A, GIM (fields away from the cancer area) from patients with gastric carcinoma (n=60); group B, GIM with chronic gastritis (without gastric carcinoma) (n=72); and group C, chronic gastritis without GIM (n=18). Results: Fifty six of 60 (93%) patients with GIM (both goblet and non-goblet metaplastic cells) from group A reacted intensely with mAb Das-1. Cancer areas from the same 56 patients also reacted. In contrast, 25/72 (35%) samples of GIM from patients in group B reacted with mAb Das-1 (group A v B, p<0.0001 ). None of the samples from group C reacted with the mAb. Conclusions: Reactivity of mAb Das-1 is clinically useful to simplify and differentiate the phenotypes of GIM. The colonic phenotype of GIM, as identified by mAb Das-1, is strongly associated with gastric carcinoma.

Original languageEnglish
Pages (from-to)807-812
Number of pages6
JournalGut
Volume52
Issue number6
DOIs
StatePublished - Jun 1 2003
Externally publishedYes

Fingerprint Dive into the research topics of 'Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma'. Together they form a unique fingerprint.

  • Cite this

    Mirza, Z. K., Das, K. K., Slate, J., Mapitigama, R. N., Amenta, P. S., Griffel, L. H., Ramsundar, L., Watari, J., Yokota, K., Tanabe, H., Sato, T., Kohgo, Y., & Das, K. M. (2003). Gastric intestinal metaplasia as detected by a monoclonal antibody is highly associated with gastric adenocarcinoma. Gut, 52(6), 807-812. https://doi.org/10.1136/gut.52.6.807